Inside Look: NYCFC’s New HOK-Designed Stadium
In April 2024, the New York City Council officially approved the transformational Willets Point Phase II Redevelopment Plan, which includes a new soccer-spec…
In April 2024, the New York City Council officially approved the transformational Willets Point Phase II Redevelopment Plan, which includes a new soccer-spec…
Music, tour dates, videos and more from Young the Giant.
Join us in recognizing the American Heart Association’s 2024 National Volunteer Awardees. Together, let’s celebrate the power of volunteerism and the impact …
Objectives Although controversial, recent data suggest nighttime versus daytime laparoscopic cholecystectomy (LC) have comparable outcomes. Laparoscopic common bile duct exploration (LCBDE) for choledocholithiasis decreases length…
Mayo Clinic researchers have developed a new scoring tool that links Alzheimer’s disease subtypes with age of onset and the […]
Ischemic heart disease (IHD) is the leading cause of morbidity and mortality in both genders; however, young women fare the worst, likely reflecting the more…
“AEACaP” Asociación Española de Afectados de Cáncer de Pulmón.Séptimo capítulo del Proyecto A Pulmón en el que ascendemos al techo de Euskadi: Aizkorri (1.52…
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Going forward, data from these kinds of studies could increasingly be used by AI to help personalize therapy for HF patients, an editorial suggests.
Left Ventricular Assist Devices buy precious time for patients on heart transplant waiting lists.
AbstractBackground and Aims. APOC3, ANGPTL3, and ANGPTL4 are circulating proteins that are actively pursued as pharmacological targets to treat dyslipidemi